Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes

2016/10/19 by Mariya Markova, Olga Pivovarova, Olga Pivovarova‐Ramich +21 · 27 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Liver Disease Diagnosis and Treatment #Fibroblast Growth Factor Research #Diet and metabolism studies

paper · doi:10.1053/j.gastro.2016.10.007

Citations

• Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
• Splanchnic lipolysis in human obesity
• Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial
• FGF21 is an endocrine signal of protein restriction

Cited by

• Effect of Plant Versus Animal Protein on Muscle Mass, Strength, Physical Performance, and Sarcopenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials
• Affordability of Different Isocaloric Healthy Diets in Germany—An Assessment of Food Prices for Seven Distinct Food Patterns
• Ectopic Fat Accumulation in Distinct Insulin Resistant Phenotypes; Targets for Personalized Nutritional Interventions. [europepmc]
• ESPEN guideline on clinical nutrition in liver disease. [europepmc]
• Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application. [europepmc]
• Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease. [europepmc]
• Nonalcoholic Fatty Liver Disease and Obesity Treatment. [europepmc]
• Dietary Protein and Changes in Biomarkers of Inflammation and Oxidative Stress in the Framingham Heart Study Offspring Cohort. [europepmc]
• Effects of Full-Fat and Fermented Dairy Products on Cardiometabolic Disease: Food Is More Than the Sum of Its Parts. [europepmc]
• Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial. [europepmc]
• Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review. [europepmc]
• Lifestyle modification in NAFLD/NASH: Facts and figures. [europepmc]
• Physical Activity and Diet Shape the Immune System during Aging. [europepmc]
• Metabolic liver disease in diabetes - From mechanisms to clinical trials. [europepmc]
• Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease. [europepmc]
• Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. [europepmc]
• NAFLD as a continuum: from obesity to metabolic syndrome and diabetes. [europepmc]
• A Fad too Far? Dietary Strategies for the Prevention and Treatment of NAFLD. [europepmc]
• Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. [europepmc]
• Plant Proteins: Assessing Their Nutritional Quality and Effects on Health and Physical Function. [europepmc]
• Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease. [europepmc]
• Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants. [europepmc]
• The Effect of Antioxidant and Anti-Inflammatory Capacity of Diet on Psoriasis and Psoriatic Arthritis Phenotype: Nutrition as Therapeutic Tool? [europepmc]
• The Low-Carbohydrate Diet: Short-Term Metabolic Efficacy Versus Longer-Term Limitations. [europepmc]
• Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. [europepmc]
• Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). [europepmc]
• Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. [europepmc]